A severe case of rhabdomyolysis after Moderna <scp>mRNA anti‐COVID</scp>‐19 vaccine with a literature review-Reference-Cited by-同舟云学术

A severe case of rhabdomyolysis after Moderna mRNA anti‐COVID‐19 vaccine with a literature review

Published:2023-05 Issue:5 Volume:11 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Sheka Maria¹^ORCID,Coattrenec Yann²³,Lorenzini Kuntheavy Ing³⁴^ORCID,Nendaz Mathieu¹³

Affiliation:

1. Department of Medicine, Division of General Internal Medicine Geneva University Hospitals Geneva Switzerland

2. Department of Medicine, Division of Immunology and Allergology Geneva University Hospitals Geneva Switzerland

3. Department of Medicine Geneva University Hospitals and Faculty of Medicine, University of Geneva Geneva Switzerland

4. Department of Anesthesiology, Pharmacology, Division of Clinical Pharmacology and Toxicology, Intensive Care and Emergency Medicine Geneva University Hospitals Geneva Switzerland

Abstract

AbstractThe identification of rhabdomyolysis as a potential fatal adverse reaction to recent COVID‐19 vaccines is essential. As the symptoms of rhabdomyolysis are not specific, the threshold to actively search for this complication should be low.

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.7184

Reference34 articles.

1. The syndrome of rhabdomyolysis: Pathophysiology and diagnosis

2. Fatal Case of Rhabdomyolysis Post-COVID-19 Vaccine

3. Fatal thrombotic microangiopathy with rhabdomyolysis as an initial symptom after the first dose of mRNA–1273 vaccine: A case report

4. Case Report: Severe Rhabdomyolysis and Multiorgan Failure After ChAdOx1 nCoV-19 Vaccination

5. Fatal myositis, rhabdomyolysis and compartment syndrome after ChAdOx1 nCoV-19 vaccination

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Musculoskeletal manifestations of COVID-19;Skeletal Radiology;2023-12-20

2. Elasomeran;Reactions Weekly;2023-08-12